Stay updated on Eplontersen in ATTR CM: Clinical Trial
Sign up to get notified when there's something new on the Eplontersen in ATTR CM: Clinical Trial page.

Latest updates to the Eplontersen in ATTR CM: Clinical Trial page
- CheckyesterdayChange DetectedThe webpage has undergone significant updates, including the addition of new facility names and locations, as well as detailed drug information for Eplontersen. The revision number has also been updated to v3.0.0.SummaryDifference4%
- Check9 days agoNo Change Detected
- Check16 days agoChange DetectedThe page has been updated to reflect the latest version as v2.16.12, replacing the previous version v2.16.11. The phrasing regarding the last update has also changed from 'Estimated' to a definitive statement.SummaryDifference0.1%
- Check23 days agoChange DetectedThe page has been updated to reflect a reduction in the number of study locations from 144 to 142, and it now includes a new location, Azienda Ospedaliero Universitaria Delle Marche. Additionally, the last update date has been changed to August 8, 2025.SummaryDifference1%
- Check30 days agoChange DetectedThe page has been updated to reflect the latest version as v2.16.10, and the previous service alert regarding planned maintenance has been removed.SummaryDifference0.8%
- Check37 days agoChange DetectedThe webpage has been updated to reflect a new clinical trial involving eplontersen, with changes in participant numbers, study timelines, and specific outcomes measured, including cardiovascular mortality and clinical events. Additionally, the collaborators have been updated to include AstraZeneca.SummaryDifference8%
- Check44 days agoChange DetectedThe web page has been updated from version 2.16.5 to version 2.16.6.SummaryDifference0.1%
Stay in the know with updates to Eplontersen in ATTR CM: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Eplontersen in ATTR CM: Clinical Trial page.